These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 2930627
1. Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile. McGown AT, Fox BW. Anticancer Drug Des; 1989 Mar; 3(4):249-54. PubMed ID: 2930627 [Abstract] [Full Text] [Related]
2. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4. Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG. Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804 [Abstract] [Full Text] [Related]
3. Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Lin CM, Ho HH, Pettit GR, Hamel E. Biochemistry; 1989 Aug 22; 28(17):6984-91. PubMed ID: 2819042 [Abstract] [Full Text] [Related]
4. Antimitotic and antitubulin activity of the tumor inhibitor steganacin. Wang RW, Rebhum LI, Kupchan SM. Cancer Res; 1977 Sep 22; 37(9):3071-9. PubMed ID: 560248 [Abstract] [Full Text] [Related]
5. Interaction of the novel agent amphethinile with tubulin. McGown AT, Fox BW. Br J Cancer; 1989 Jun 22; 59(6):865-8. PubMed ID: 2736224 [Abstract] [Full Text] [Related]
6. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1). Pettit GR, Minardi MD, Rosenberg HJ, Hamel E, Bibby MC, Martin SW, Jung MK, Pettit RK, Cuthbertson TJ, Chapuis JC. J Nat Prod; 2005 Oct 22; 68(10):1450-8. PubMed ID: 16252907 [Abstract] [Full Text] [Related]
7. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin. Rappl C, Barbier P, Bourgarel-Rey V, Grégoire C, Gilli R, Carre M, Combes S, Finet JP, Peyrot V. Biochemistry; 2006 Aug 01; 45(30):9210-8. PubMed ID: 16866367 [Abstract] [Full Text] [Related]
14. Structure-based discovery of a boronic acid bioisostere of combretastatin A-4. Kong Y, Grembecka J, Edler MC, Hamel E, Mooberry SL, Sabat M, Rieger J, Brown ML. Chem Biol; 2005 Sep 07; 12(9):1007-14. PubMed ID: 16183025 [Abstract] [Full Text] [Related]
17. 3-(3,4,5-Trimethoxyphenylselenyl)-1H-indoles and their selenoxides as combretastatin A-4 analogs: microwave-assisted synthesis and biological evaluation. Wen Z, Xu J, Wang Z, Qi H, Xu Q, Bai Z, Zhang Q, Bao K, Wu Y, Zhang W. Eur J Med Chem; 2015 Jan 27; 90():184-94. PubMed ID: 25461319 [Abstract] [Full Text] [Related]
18. Inhibition of [3H]mebendazole binding to tubulin by structurally diverse microtubule inhibitors which interact at the colchicine binding site. Russell GJ, Lacey E. Biochem Mol Biol Int; 1995 May 27; 35(6):1153-9. PubMed ID: 7492951 [Abstract] [Full Text] [Related]
20. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues. Blokhin AV, Yoo HD, Geralds RS, Nagle DG, Gerwick WH, Hamel E. Mol Pharmacol; 1995 Sep 27; 48(3):523-31. PubMed ID: 7565634 [Abstract] [Full Text] [Related] Page: [Next] [New Search]